Dolby Laboratories, Inc. — Director's Dealing 2019

Mar 28, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dolby Laboratories, Inc. (DLB)
CIK: 0001308547
Period of Report: 2019-03-25

Reporting Person: YEAMAN KEVIN J (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-25	Performance-Based Stock Option (Right to Buy)	$64.60	G	82000	Disposed	2025-12-17	Class A Common Stock (82000)	Direct
2019-03-25	Performance-Based Stock Option (Right to Buy)	$64.60	G	82000	Acquired	2025-12-17	Class A Common Stock (82000)	Indirect
2019-03-25	Employee Stock Option (Right to Buy)	$64.60	G	164000	Disposed	2028-12-17	Class A Common Stock (164000)	Direct
2019-03-25	Employee Stock Option (Right to Buy)	$64.60	G	164000	Acquired	2028-12-17	Class A Common Stock (164000)	Indirect

Footnotes

F1: Effective March 25, 2019 the Reporting Person transferred this option as a gift to a revocable trust.

F2: The vesting of this performance-based stock option ("PSO") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 17, 2018 and ending December 17, 2021. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 125% of the target award amount based on total shareholder return at the end of the three-year performance period. The actual PSO award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period.

F3: This option was granted for a total of 164,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 17, 2018, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter.